Related Experiment Video
Updated: Aug 6, 2025
Author Spotlight: Generation of Patient-Derived Podocytes from Skin Biopsies
Published on: May 26, 2023
From bench to bedside: lessons learned from translational podocyte research
Olivia Lenoir1, Tobias B Huber2, Pierre-Louis Tharaux3
1Université Paris Cité, Inserm, Paris Cardiovascular Research Center (PARCC), Paris, France.
Abstract:
Polat et al. report that mice with a podocyte-specific expression of a constitutively active Rac1 form displayed similar injury and albuminuria, regardless of transient receptor potential canonical 5 activity. This article confirms the pathogenic role of deregulated Rac1 and challenges models involving the role of transient receptor potential canonical 5 in podocytes. We learned from this study and propose a roadmap for this controversial field to help new drug candidates succeed in clinical trials and safely reach patients.
Insights
Deregulated Rac1 causes kidney podocyte injury and albuminuria, independent of transient receptor potential canonical 5 channels. This finding challenges current models and offers a roadmap for developing new kidney disease therapies.
Area of Science:
- Nephrology
- Molecular Biology
- Cell Biology
Background:
- Podocyte injury is a key factor in kidney disease progression.
- The role of Rac1 and transient receptor potential canonical 5 (TRPC5) in podocyte function is debated.
- Understanding these pathways is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the role of constitutively active Rac1 in podocyte injury.
- To determine if TRPC5 activity is necessary for Rac1-induced podocyte damage.
- To clarify the pathogenic mechanisms in podocyte dysfunction.
Main Methods:
- Generation of transgenic mice with podocyte-specific expression of constitutively active Rac1.
- Assessment of kidney injury markers, including albuminuria.
- Evaluation of TRPC5 activity in the context of Rac1-induced injury.
Main Results:
- Podocyte-specific expression of active Rac1 led to significant kidney injury and albuminuria.
- The observed injury and albuminuria were independent of TRPC5 activity.
- These findings confirm Rac1's pathogenic role and challenge TRPC5's involvement.
Conclusions:
- Deregulated Rac1 is a key driver of podocyte injury and albuminuria.
- TRPC5 is not essential for Rac1-mediated podocyte damage.
- This study provides a revised roadmap for research into podocyte-related kidney diseases and therapeutic development.
